Trial Profile
Phase I/II trial of Autologous Platelet Integrated Concentration (APIC) cell-free system for the rapid preparation of concentrated protease inhibitor alpha-2-macroglobulin (A2M) for the treatment of mild to moderate osteoarthritis of the knee
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 25 May 2015
Price :
$35
*
At a glance
- Drugs Alpha 2-macroglobulin (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 25 May 2015 New trial record